NCT00460031View on ClinicalTrials.gov

Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

September 1, 2006

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Prostate Cancer
Interventions
DRUG

ketoconazole

400 tid

DRUG

lenalidomide

Lenalidomide will be administered daily at a dose of 25mg po qd on days 1-21 of the cycle.

DRUG

therapeutic hydrocortisone

20mg qam 10mg qhs

Trial Locations (6)

44060

Lake/University Seidman Cancer Center, Cleveland

44121

University Suburban Health Center, Cleveland

44122

UHHS Chagrin Highlands Medical Center, Cleveland

44145

UHHS Westlake Medical Center, Cleveland

44195

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland

44106-5065

University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors
lead

Case Comprehensive Cancer Center

OTHER

NCT00460031 - Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy | Biotech Hunter | Biotech Hunter